Trade Summary

2 days ago, Partridge Andrew John, serving as Chief Growth Officer at GRAIL, Inc. (GRAL), sold 1,491 shares at $61.08 per share, for a total transaction value of $91,070.28. Following this transaction, Partridge Andrew John now holds 163,738 shares of GRAL.

This sale represents a 0.90% decrease in Partridge Andrew John's stake in the company.

The trade was executed on Thursday, June 4, 2026 and publicly disclosed via SEC Form 4 filing on Saturday, June 6, 2026 (accepted Jun 5, 8:16 PM ET), 2 days after the trade was made.

GRAIL, Inc. operates in the HEALTHCARE sector, specifically within the DIAGNOSTICS & RESEARCH industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.